Boston-based Covant Therapeutics gained $10 million upfront in a deal with Boehringer Ingelheim to chase after a cancer immunotherapy target, ADAR1.
Covant Therapeutics Debuts with Boehringer Partnership Targeting ADAR1 Read More »
Amazon Pharmacy is currently offering coupons for eight brand name medications treating diabetes, asthma, obesity, emphysema and others, and said it plans to add more coupons over time.
Amazon Pharmacy adds manufacturer coupons for some brand name drugs Read More »
The company, which reported a net loss on Tuesday, is also exploring strategic alternatives for its Xoft therapy business.
Breast cancer AI company iCAD lays off workers, names new CEO Read More »
The FDA could decline premarket submissions that lack adequate cybersecurity information.
Device cybersecurity enforcement delayed to October: FDA Read More »
The groups argue the expansion of the FCA would threaten the “legitimate business activities of every government contractor, hospital, healthcare provider, health insurance provider, and grant recipient in the nation.”
AHIP, AHA join forces in amicus brief to SCOTUS False Claims Act case Read More »
Expenses were still high in February, though rising prices for goods and services were more to blame than costly labor, according to the report.
Hospital margins stabilizing after year in negatives, Kaufman Hall says Read More »
El movimiento de un animal depende de la capacidad de las neuronas para transportar señales desde el centro de la célula (cuerpo celular) hacia proyecciones estrechas conocidas como axones. En los humanos, los axones pueden alcanzar hasta un metro de longitud. Esto implica que pueden l …
Tuesday, Viking Therapeutics released Phase I results for its weight-loss candidate VK2735, which demonstrated a good safety and tolerability profile and resulted in significant weight reductions.
Viking Enters Weight-Loss Arena with Promising Phase I Data Read More »
Intra-Cellular Therapies’ Caplyta met its primary endpoint in the Phase III Study 403 trial, easing the burden of depressive episodes in patients with major depressive disorder or bipolar depression.
Positive Phase III Builds Case for Intra-Cellular’s Depression Drug Read More »
Una investigación reciente ha permitido averiguar que la desregulación del gen SOCS3 contribuye a la activación de una vía de señalización celular en tumores hematológicos agresivos. Los autores de este estudio, entre quienes figuran Antonio …
Potencial diana terapéutica contra tumores hematológicos agresivos Read More »
